Accueil>>Signaling Pathways>> MAPK Signaling>> MEK1/2>>Balamapimod (MKI 833)

Balamapimod (MKI 833) (Synonyms: MKI 833)

Catalog No.GC33305

Balamapimod (MKI 833) (MKI 833) est un inhibiteur réversible de Ras/Raf/MEK avec une activité anti-tumorale potentielle.

Products are for research use only. Not for human use. We do not sell to patients.

Balamapimod (MKI 833) Chemical Structure

Cas No.: 863029-99-6

Taille Prix Stock Qté
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Balamapimod (MKI 833) is a reversible Ras/Raf/MEK inhibitor with potential anti-tumor activity.

[1]. Jose R. Conejo-Garcia, et al. Methods and compositions for treatment of metastatic and refractory cancers and tumors. US20170020964A1.

Avis

Review for Balamapimod (MKI 833)

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Balamapimod (MKI 833)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.